Varying results in amyloid deposition have been shown in AD mouse models lacking the LDLR, with one study showing that amyloid deposition was enhanced on a LDLR null background [25], while in another study, LDLR deficiency had no effect on brain amyloid-β peptides (Aβ) levels [26]. This evidence concerns the gene LDLR and Alzheimer disease.